CRMD · CorMedix Inc
United States · RS rating 18 · As of 2026-11-03
| Price | 5.56 USD |
|---|---|
| 1-day change | +3.1% |
| RS rating (overall / 1M / 3M / 12M) | 18 / 18 / 26 / 21 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 20 / 5 / 11 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -87.3% |
| Sales growth Q/Q | +23.3% |
| Distance from 52-week high | +56.3% |
| Market cap (USD) | $579.4M |